INCREASING RELATIVE SURVIVAL IN CHRONIC MYELOID LEUKEMIA (CML): A POPULATION-BASED STUDY IN LITHUANIA

被引：0
|
作者：
Zvirblis, T. [1 ]
Ivanauskaite, V. [1 ]
Tavoriene, I. [1 ]
Gerbutavicius, R. [2 ]
Juozaityte, E. [2 ]
Malciute, L. [3 ]
Jurgutis, M. [3 ]
Daubariene, J. [4 ]
Ramanauskiene, D. [5 ]
Rageliene, L. [1 ]
Griskevicius, L. [1 ]
机构：
[1] Vilnius Univ Hosp, Santariskiu Clin, Vilnius, Lithuania
[2] Hosp Lithuanian Univ Hlth Sci, Kaunas Clin, Kaunas, Lithuania
[3] Klaipeda Seamens Hosp, Klaipeda, Lithuania
[4] Panevezys Hosp, Panevezys, Lithuania
[5] Siauliai Hosp, Shiauliai, Lithuania
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0768
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [1] Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study
    Al-Husseini, Muneer J.
    Mohamed, Hadeer H.
    Saad, Anas M.
    Gad, Mohamed M.
    Atia, Mona
    Qaddoora, Umniyah
    Abushouk, Abdelrahman Ibrahim
    El-Shinawi, Mohamed
    CURRENT PROBLEMS IN CANCER, 2019, 43 (03) : 213 - 221
  • [2] Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989–2017
    Geneviève I. C. G. Ector
    Otto Visser
    Peter E. Westerweel
    Jeroen J. W. M. Janssen
    Nicole M. A. Blijlevens
    Avinash G. Dinmohamed
    Leukemia, 2020, 34 : 3408 - 3412
  • [3] The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
    Enza Di Felice
    Francesca Roncaglia
    Francesco Venturelli
    Lucia Mangone
    Stefano Luminari
    Claudia Cirilli
    Giuliano Carrozzi
    Paolo Giorgi Rossi
    BMC Cancer, 18
  • [4] The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
    Di Felice, Enza
    Roncaglia, Francesca
    Venturelli, Francesco
    Mangone, Lucia
    Luminari, Stefano
    Cirilli, Claudia
    Carrozzi, Giuliano
    Rossi, Paolo Giorgi
    BMC CANCER, 2018, 18
  • [5] Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study
    Michael Lauseker
    Roman Gerlach
    Martin Tauscher
    Joerg Hasford
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1441 - 1447
  • [6] Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study
    Lauseker, Michael
    Gerlach, Roman
    Tauscher, Martin
    Hasford, Joerg
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (07) : 1441 - 1447
  • [7] Survival for older patients with acute myeloid leukemia: a population-based study
    Oran, Betul
    Weisdorf, Daniel J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (12): : 1916 - 1924
  • [8] Correction: Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989–2017
    Geneviève I. C. G. Ector
    Otto Visser
    Peter E. Westerweel
    Jeroen J. W. M. Janssen
    Nicole M. A. Blijlevens
    Avinash G. Dinmohamed
    Leukemia, 2020, 34 : 3440 - 3440
  • [9] Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017
    Ector, Genevieve I. C. G.
    Visser, Otto
    Westerweel, Peter E.
    Janssen, Jeroen J. W. M.
    Blijlevens, Nicole M. A.
    Dinmohamed, Avinash G.
    LEUKEMIA, 2020, 34 (12) : 3408 - 3412
  • [10] Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the Netherlands
    Geneviève I. C. G. Ector
    Otto Visser
    Eduardus F. M. Posthuma
    Peter E. Westerweel
    Jeroen J. W. M. Janssen
    Nicole M. A. Blijlevens
    Avinash G. Dinmohamed
    Leukemia, 2021, 35 : 3291 - 3294
12345